Inhibrx Biosciences, Inc. (INBX)

Inhibrx Biosciences Revenue

Inhibrx Biosciences had revenue of $1.40M in the twelve months ending September 30, 2025, down -19.26% year-over-year. In the year 2024, Inhibrx Biosciences had annual revenue of $200.00K, down -88.89%.

• Revenue (ttm): $1.40M
• Revenue Growth: -19.26%
• P/S Ratio: 770.09
• Revenue / Employee: $8,696
• Employees: 161
• Market Cap: 1.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	200.00K	-1.60M	-88.89%
Dec 31, 2023	1.80M	-392.00K	-17.88%
Dec 31, 2022	2.19M	-5.04M	-69.69%
Dec 31, 2021	7.23M	-5.66M	-43.89%
Dec 31, 2020	12.89M	-323.00K	-2.44%
Dec 31, 2019	13.21M	4.62M	53.71%
Dec 31, 2018	8.60M	204.00K	2.43%
Dec 31, 2017	8.39M	1.72M	25.86%
Dec 31, 2016	6.67M	-	-